Finance

Lists
HNSA:STO
Hansa Biopharma AB
40,72 SEK
+7,61%
(+2,88) 1D
7 там., 17:29:55 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for HNSA...
Open
37,84 SEK
High
41,10 SEK
Low
37,68 SEK
Mkt. cap
4,14 млрд
Avg. vol.
702,84 м.
Volume
1,19 млн
52-wk high
43,80 SEK
52-wk low
23,52 SEK
EPS
-7,90 SEK
Shares outstanding
101,76 млн
No. of employees
131
Open
37,84 SEK
High
41,10 SEK
Low
37,68 SEK
Mkt. cap
4,14 млрд
Avg. vol.
702,84 м.
Volume
1,19 млн
52-wk high
43,80 SEK
52-wk low
23,52 SEK
EPS
-7,90 SEK
Shares outstanding
101,76 млн
No. of employees
131
About Hansa Biopharma AB
CEOSøren Tulstrup
Employees131
Founded2007
Headquarters-
Sector-
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
30,80 млн
75,99 млн
34,57 млн
48,10 млн
Cost of goods sold
20,11 млн
24,66 млн
13,78 млн
22,33 млн
Cost of revenue
20,11 млн
24,66 млн
13,78 млн
22,33 млн
Research and development expenses
70,21 млн
74,43 млн
57,34 млн
67,87 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
88,41 млн
101,62 млн
105,56 млн
118,93 млн
Operating expense
160,41 млн
176,02 млн
162,90 млн
186,83 млн
Total operating expenses
180,52 млн
200,67 млн
176,68 млн
209,16 млн
Operating income
-149,71 млн
-124,68 млн
-142,11 млн
-161,06 млн
Other non operating income
-
-
1,38 млн
-30,53 млн
EBT including unusual items
-147,56 млн
-169,50 млн
-195,87 млн
-259,86 млн
EBT excluding unusual items
-147,56 млн
-169,50 млн
-195,87 млн
-259,86 млн
Income tax expense
693,00 м.
396,00 м.
453,00 м.
677,00 м.
Effective tax rate
-0,47%
-0,23%
-0,23%
-0,26%
Other operating expenses
1,79 млн
-34,00 мың
-
28,00 мың
Net income
-148,26 млн
-169,90 млн
-196,32 млн
-260,54 млн
Net profit margin
-481,29%
-223,58%
-567,89%
-541,71%
Earnings per share
-1,75
-1,62
-1,93
-2,26
Interest and investment income
10,28 млн
-
2,55 млн
3,20 млн
Interest expense
-10,23 млн
-208,06 млн
-28,90 млн
-58,48 млн
Net interest expenses
49,00 мың
-208,06 млн
-26,35 млн
-55,27 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-149,07 млн
-124,05 млн
-141,48 млн
-149,39 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google қолданбалары